Sana Biotechnology, Inc.
SANA
$1.76
-$0.01-0.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.63% | 0.61% | 14.51% | 19.95% | 25.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.96% | -5.36% | -14.76% | 14.41% | 24.43% |
| Operating Income | 16.96% | 5.36% | 14.76% | -14.41% | -24.43% |
| Income Before Tax | 5.82% | -10.97% | 32.29% | 3.61% | -5.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.82% | -10.97% | 32.29% | 3.61% | -5.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.82% | -10.97% | 32.29% | 3.61% | -5.11% |
| EBIT | 16.96% | 5.36% | 14.76% | -14.41% | -24.43% |
| EBITDA | 17.26% | 5.16% | 15.34% | -15.01% | -25.19% |
| EPS Basic | 19.95% | 2.01% | 39.24% | 9.45% | -2.51% |
| Normalized Basic EPS | 29.88% | 15.93% | 23.23% | -6.03% | -18.67% |
| EPS Diluted | 19.94% | 2.02% | 39.24% | 9.47% | -2.49% |
| Normalized Diluted EPS | 29.67% | 15.67% | 23.51% | -5.72% | -18.31% |
| Average Basic Shares Outstanding | 18.68% | 14.69% | 10.81% | 6.00% | 3.29% |
| Average Diluted Shares Outstanding | 18.15% | 14.17% | 11.27% | 6.47% | 3.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |